Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2002
10/31/2002US20020161440 Dermal scaffold using alkaline pre-treated chitosan matrix or alkaline pre-treated chitosan and alkaline pre-treated collagen mixed matrix
10/31/2002US20020161215 For use in assays designed to identify and characterize compounds which affect the function of such receptors, e.g., agonists and antagonists of NMDA receptors
10/31/2002US20020161213 Novel human kinases and polynucleotides encoding the same
10/31/2002US20020161212 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells
10/31/2002US20020161208 Useful for diagnosing, therapy, prophylaxis and/or prognosing disorders related to these novel polypeptides
10/31/2002US20020161202 For modulating apoptosis in mammalian cells
10/31/2002US20020161201 For use in cancer diagnosis and therapy
10/31/2002US20020161200 For therapy
10/31/2002US20020161197 Defibrinating whole blood including red blood cells and a plasma component; filtering whole blood, whereby at least a portion of plasma is separated from red blood cells to form a red blood cell suspension, thereby purifying red blood cells
10/31/2002US20020161196 Trail receptors nucleic acids encoding the same and methods of use thereof
10/31/2002US20020161195 Trail receptors, nucleic acids encoding the same, and methods of use thereof
10/31/2002US20020161193 Useful for the production of NMDA receptor subunit proteins, these nucleic acids are also useful as probes, to identify and isolate related human receptor subunits
10/31/2002US20020161191 Novel Imidazoline receptor homologs
10/31/2002US20020161178 Novel DKR polypeptides
10/31/2002US20020160971 Retroviral vectors with foreign-sequence insertion between retroviral primer binding site and retroviral splice donor
10/31/2002US20020160959 Therapeutic compounds for ovarian cancer
10/31/2002US20020160940 Modulation of endogenous gene expression in cells
10/31/2002US20020160513 For obtaining stable mass propagation and transformation system of the Ficus stipulata Thunb
10/31/2002US20020160512 Culturing isolated hematopoietic stem cells (HSC) in culture system comprising culture medium in presence of stem cell expansion promoting factor (SCEPF) which is produced by culturing murine stromal cells
10/31/2002US20020160511 For use in drug screening, and replenishing liver function in the context of clinical treatment
10/31/2002US20020160510 Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
10/31/2002US20020160509 For use in transplantation or drug screening and drug discovery in vitro
10/31/2002US20020160501 Methods for generating high titer helper-free preparations of released recombinant AAV vectors
10/31/2002US20020160500 Glutaryl cephalosporin amidase from pseudomonas diminuta BS-203
10/31/2002US20020160499 For use in diagnosis, prophylaxis, and therapy of disorders associated with expression of serine carboxypeptidase
10/31/2002US20020160494 Tendon-inducing compositions
10/31/2002US20020160493 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies
10/31/2002US20020160487 Testis specific transcription factor ZGCL-1
10/31/2002US20020160481 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof
10/31/2002US20020160477 CAF1-related protein
10/31/2002US20020160473 Far red shifted fluorescent proteins
10/31/2002US20020160471 Peptide scaffold encapsulation of tissue cells and uses thereof
10/31/2002US20020160470 Methods and apparatus for generating and utilizing linear moving optical gradients
10/31/2002US20020160468 Using nicotinamide-adenine dinucleotide coenzyme
10/31/2002US20020160458 Gene expression of endoprotease in eukaryotic cells; yeast culture product
10/31/2002US20020160455 Methods and host cells for improved cell culture
10/31/2002US20020160448 Human c-Maf compositions and methods of use thereof
10/31/2002US20020160447 Ups (ugc)
10/31/2002US20020160430 Methods and compositions for obtaining mature dendritic cells
10/31/2002US20020160429 Using antibody released by hybridomas cells
10/31/2002US20020160425 Process for differential diagnosis of Alzheimer's dementia and device therefor
10/31/2002US20020160393 Controlling gene expression in eukaryotic cells
10/31/2002US20020160392 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/31/2002US20020160384 Polypeptides; binding to antibodies
10/31/2002US20020160374 Fusion protein; genetic engineering; binding to antibodies
10/31/2002US20020160359 Stabilizing diluent for polypeptides and antigens
10/31/2002US20020160052 Tissue graft composition comprising liver basement membrane; graft composition can be implanted to replace or induce repair of damaged or diseased tissues
10/31/2002US20020160024 Modulating movement of a cell within or to the skin of a mammal by administering to mammal an effective amount of an antagonist an agonist of CTACK, an antagonist or agonist of Vic chemokines
10/31/2002US20020160015 Chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes and its uses
10/31/2002US20020160010 Use of preparations containing anti-cd44 antibodies in the treatment of certain tumours and the suppression of immune reactions
10/31/2002US20020160004 Antibodies against flt3-ligand
10/31/2002US20020160003 Antibody antagonists of VE-cadherin without adverse effects on vascular permeability
10/31/2002US20020160002 SseCKS gene encodes a substrate of protein kinase C that functions as both a mitogenic regulator as well as a tumor suppressor
10/31/2002US20020159985 Forming an inactive platelet rich plasma from a single whole blood sample; dividing plasma into first and second portions, reactivating first portion to form a clot, triturating the clot to obtain a serum, mixing serum with second portion
10/31/2002US20020159984 Cultivation of cells for long term engraftment
10/31/2002US20020159983 Bioprosthetic heart valves
10/31/2002US20020159982 Injection molding of living tissues
10/31/2002US20020159981 A cell population cultured ex-vivo in a culture medium under conditions permitting cells of cell population to proliferate and at the same time reducing capacity of cells in utilizing copper, hence expanded yet not further differentiated
10/31/2002US20020159977 Administering a recombinant adeno-associated virion into human suffering from hemophilia such that factor VIII nuclotide sequence are expressed at a level which provide therapeutically effective amount in the patient
10/31/2002US20020159976 An isolated polynucleotide comprising a nucleotide sequence present in Lactobacillus rhamnosus strain HN001 that encodes a polypeptide having atleast one enzymetic activity; genetic engineering
10/31/2002US20020159975 Derivation of cells and tissues from embryonic pre-stem cells for transplantation therapies
10/31/2002US20020159958 Methods for producing immunoglobulins containing protection proteins in plants and their use
10/31/2002EP1146837A4 System and sequential culture media for in vitro fertilization
10/31/2002DE10217066A1 Composition useful for treatment of central nervous system disorders, e.g. Alzheimer's disease comprises modulator of neuron-specific calcium sensor-1
10/31/2002DE10121113A1 Genmodifizierte YT Zelllinie und ihre Verwendung Genetically Modified YT cell line and their use
10/31/2002DE10118452A1 Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse Nucleic acid sequences of hyperplasias and tumors of the thyroid
10/31/2002CA2843001A1 Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom
10/31/2002CA2807478A1 Use of follistatin to increase muscle mass
10/31/2002CA2483507A1 Enzyme and snp marker for disease
10/31/2002CA2445354A1 Nucleic acid molecules encoding starch degrading enzymes
10/31/2002CA2445258A1 Template-mediated, ligation-oriented method of nonrandomly shuffling polynucleotides
10/31/2002CA2445255A1 Vhh single heavy chain antibody and a method for its preparation in a mammal
10/31/2002CA2445197A1 T1r3 a novel taste receptor
10/31/2002CA2445179A1 Identification of essential genes of aspegillus fumigatus and methods of use
10/31/2002CA2445168A1 Human timp-1 antibodies
10/31/2002CA2445011A1 Transformed silkworm producing human collagen
10/31/2002CA2444959A1 Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom
10/31/2002CA2444706A1 Isolation of neural stem cells using gangliosides and other surface markers
10/31/2002CA2444691A1 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
10/31/2002CA2444675A1 Secreted proteins
10/31/2002CA2444621A1 A method of nuclear transfer
10/31/2002CA2444594A1 Sprr1a and axonal regeneration
10/31/2002CA2444235A1 New polynucleotides and polypeptides of the ifn.alpha.-17 gene
10/31/2002CA2444195A1 Compositions and methods for recombinational cloning of nucleic acid molecules
10/31/2002CA2444098A1 Methods and compositions for the production of orthogonal trna-aminoacyl trna synthetase pairs
10/31/2002CA2443757A1 In vivo incorporation of unnatural amino acids
10/31/2002CA2443373A1 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002CA2441783A1 Genes involved in isoprenoid compound production
10/31/2002CA2439693A1 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
10/31/2002CA2429351A1 A novel human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof
10/30/2002EP1253202A1 Expression cassette comprising the Arabidopsis thaliana trehalose-6-phosphate synthase 3 (TPS3) promoter for strong constitutive gene expression
10/30/2002EP1253201A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
10/30/2002EP1253200A1 Cocoa polypeptides and their use in the production of cocoa and chocolate flavour
10/30/2002EP1253198A1 Plant adpglucose pyrophosphatase, method for the production thereof, its use in the production of assay devices and for obtaining transgenic plants
10/30/2002EP1253196A2 Substratum for cell culture, production of the same, cell culture method and cell culture apparatus using the same
10/30/2002EP1252818A1 Method of transferring mutant mitochondrial dna into genital cells
10/30/2002EP1252337A2 Nucleic acids, proteins, and antibodies
10/30/2002EP1252333A2 Methods and materials relating to cd84-like polypeptides and polynucleotides
10/30/2002EP1252321A1 Replication deficient adenovirus vectors
10/30/2002EP1252318A2 Allene oxide cyclase gene and use thereof for producing jasmonic acid
1 ... 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 ... 1827